Press Releases Avenir Wellness Solutions, Inc.

Equities

AVRW

US23127P1049

Market Closed - OTC Markets Other stock markets 14:30:03 10/05/2024 BST			5-day change	1st Jan Change
0.0331 ^USD	0.00%		-15.13%	-55.51%

01-12	Avenir Wellness Solutions, Inc. and Nancy Duitch Enters into Certain Senior Secured Promissory Note and Security Agreement	CI
01-04	Avenir Wellness Solutions, Inc. announced that it expects to receive $0.25 million in funding	CI

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Avenir Wellness Solutions Reports Second Quarter 2023 Results	16/08/23	AQ
Avenir Wellness Solutions Reports First Quarter 2023 Results with Strong Sequential and Year over Year Revenue Increases and Continued High Gross Margins	01/08/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)	22/05/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant (form 8-K)	20/04/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	19/04/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	08/03/23	AQ
AVENIR WELLNESS SOLUTIONS, INC. : Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	17/01/23	AQ
CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21/11/22	AQ
Avenir Wellness Solutions to Present at Investor Summit Group's Q4 Conference	11/11/22	NE
Cure Pharmaceutical Holding to Present at the LD Micro Main Event XV	24/10/22	NE
Cure Pharmaceutical Reports Second Quarter 2022 Results with Increased Sequential Revenues and Strong Margins	05/09/22	AQ
CURE PHARMACEUTICAL HOLDING CORP. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	02/09/22	AQ
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	02/09/22	GL
Cure Pharmaceutical Reports Second Quarter 2022 Results With Increased Sequential Revenues and Strong Margins	02/09/22	AQ
CURE PHARMACEUTICAL HOLDING CORP. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	19/08/22	AQ
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	16/08/22	GL
CURE Pharmaceutical Announces Rob Davidson as new Chairman of the Board and Appointment of Rob Costantino as Member of the Board and Audit Committee Chairman	16/08/22	AQ
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	09/08/22	GL
CURE Pharmaceutical Provided Full Corporate Update on Recent Shareholder Call	09/08/22	AQ
CURE Pharmaceutical Announces the Appointment of New Board Member	02/08/22	GL

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Avenir Wellness Solutions, Inc.

Equities

AVRW

US23127P1049

Press Releases

Filters